PatentPatent Analysis

EP2558435

LEO PHARMA
Application Number
EP11731076A
Filing Date
Apr 18, 2011
Status
Revoked
Jun 14, 2019
Grant Date
Jun 7, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2558435B1 was granted to LEO Pharma on Jun 7, 2017 following the initial filing on Apr 18, 2011 under the application number EP11731076A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMar 7, 2018ADMISSIBLE
TEVA PHARMACEUTICALSMar 7, 2018ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Get instant alerts for new documents